On October 28, 2021, Shanhe Pharmaceutical Auxiliary disclosed the third quarterly report, and the company achieved a total operating income of 450 million yuan in the first three quarters of 2021, an increase of 17.8% year-on-year; a net profit attributable to the mother of 72.542 million, an increase of 6.1% year-on-year; and earnings per share of 0.4 yuan.
Operating cash flow rose sharply by 137.7%
The company's operating costs in the third quarter of 2021 were 320 million, an increase of 21.6% year-on-year, higher than the growth rate of operating income of 17.8%, resulting in a 2.2% decline in gross profit margin. The expense ratio for the period was 11.8%, an increase of 0.6 percentage points over the previous year. Operating cash flow rose sharply by 137.7% to 37.399 million.
Disclaimer: This article is based on big data production, for reference only, does not constitute any investment advice, and operates accordingly at your own risk.